33 related articles for article (PubMed ID: 1597650)
1. Potentiation of the efficacy of murine L1210 leukemia vaccine by a novel immunostimulator 7-thia-8-oxoguanosine: increased survival after immunization with vaccine plus 7-thia-8-oxoguanosine.
Sharma BS; Balazs L; Jin A; Wang JC; Jolley WB; Robins RK
Cancer Immunol Immunother; 1991; 33(2):109-14. PubMed ID: 2036658
[TBL] [Abstract][Full Text] [Related]
2. Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.
Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K; Kuribayashi K; Saito K
Cancer Immunol Immunother; 1989; 29(2):79-86. PubMed ID: 2497980
[TBL] [Abstract][Full Text] [Related]
3. Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages.
Li H; Cao MY; Lee Y; Lee V; Feng N; Benatar T; Jin H; Wang M; Der S; Wright JA; Young AH
Cancer Immunol Immunother; 2005 Nov; 54(11):1115-26. PubMed ID: 15891881
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of antitumor natural killer cell activation by orally administered Spirulina extract in mice.
Akao Y; Ebihara T; Masuda H; Saeki Y; Akazawa T; Hazeki K; Hazeki O; Matsumoto M; Seya T
Cancer Sci; 2009 Aug; 100(8):1494-501. PubMed ID: 19432881
[TBL] [Abstract][Full Text] [Related]
5. Ascophyllan Induces Activation of Natural Killer Cells in Mice In Vivo and In Vitro.
Zhang W; Okimura T; Oda T; Jin JO
Mar Drugs; 2019 Mar; 17(4):. PubMed ID: 30925723
[TBL] [Abstract][Full Text] [Related]
6. Synergistic induction of lymphokine (IL-2)-activated killer activity by IL-2 and the polysaccharide lentinan, and therapy of spontaneous pulmonary metastases.
Yamasaki K; Sone S; Yamashita T; Ogura T
Cancer Immunol Immunother; 1989; 29(2):87-92. PubMed ID: 2785852
[TBL] [Abstract][Full Text] [Related]
7. Endogeneous interferon alpha/beta produced by murine Kupffer cells augments liver-associated natural killing activity.
Werner-Wasik M; von Muenchhausen W; Nolan JP; Cohen SA
Cancer Immunol Immunother; 1989; 28(2):107-15. PubMed ID: 2917363
[TBL] [Abstract][Full Text] [Related]
8. 7-Allyl-8-oxoguanosine (loxoribine) inhibits the metastasis of B16 melanoma cells and has adjuvant activity in mice immunized with a B16 tumor vaccine.
Pope BL; Sigindere J; Chourmouzis E; MacIntyre P; Goodman MG
Cancer Immunol Immunother; 1994 Feb; 38(2):83-91. PubMed ID: 8306370
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2.
Zhang SR; Salup RR; Urias PE; Twilley TA; Talmadge JE; Herberman RB; Wiltrout RH
Cancer Immunol Immunother; 1986; 21(1):19-25. PubMed ID: 3484675
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro induction of natural killer cells by cloned human tumor necrosis factor.
Voth R; Rossol S; Gallati H; Pracht I; Laubenstein HP; Hess G; Müller WE; Schröder HC; Jochum C; Meyer zum Büschenfelde KH
Cancer Immunol Immunother; 1988; 27(2):128-32. PubMed ID: 2458181
[TBL] [Abstract][Full Text] [Related]
11. Depression of murine natural killer cell cytotoxicity by isobutyl nitrite.
Lotzová E; Savary CA; Hersh EM; Khan AA; Rosenblum M
Cancer Immunol Immunother; 1984; 17(2):130-4. PubMed ID: 6235910
[TBL] [Abstract][Full Text] [Related]
12. Response of natural killer cells from dietary tyrosine- and phenylalanine-restricted mice to biological response modifiers.
Meadows GG; Abdallah RM; Starkey JR; Aslakson CJ
Cancer Immunol Immunother; 1988; 26(1):67-73. PubMed ID: 2964270
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of natural cell activity in tumor-bearing and normal mice by MVE-2.
Budzynski W; Chirigos M; Gruys E
Cancer Immunol Immunother; 1987; 24(3):253-8. PubMed ID: 3594488
[TBL] [Abstract][Full Text] [Related]
14. Influence of low doses of an oxazaphosphorine on natural killer activity of human lymphocytes.
Blomgren H
Cancer Immunol Immunother; 1989; 29(2):151-3. PubMed ID: 2720708
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory and therapeutic properties of FK-565 in mice.
Talmadge JE; Lenz B; Schneider M; Phillips H; Long C
Cancer Immunol Immunother; 1989; 28(2):93-100. PubMed ID: 2521814
[TBL] [Abstract][Full Text] [Related]
16. Induction of cytotoxicity of peritoneal exudate cells by agrimoniin, a novel immunomodulatory tannin of Agrimonia pilosa Ledeb.
Miyamoto K; Kishi N; Murayama T; Furukawa T; Koshiura R
Cancer Immunol Immunother; 1988; 27(1):59-62. PubMed ID: 3396026
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of new thiazolo[5,4-
Li ZH; Liu XQ; Geng PF; Ma JL; Zhao TQ; Wei HM; Yu B; Liu HM
Medchemcomm; 2017 Aug; 8(8):1655-1658. PubMed ID: 30108876
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine: I. Activation of natural killer cells in mice.
Sharma BS; Mhaskar S; Balazs L; Siaw M
Immunopharmacol Immunotoxicol; 1992; 14(1-2):1-19. PubMed ID: 1597650
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine. II. Characterization of induced effector cells and the mechanism of induction.
Sharma BS; Mhaskar S; Balazs L; Jin A; Smee DF
Immunopharmacol Immunotoxicol; 1992; 14(1-2):21-38. PubMed ID: 1375956
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
